Cite
HARVARD Citation
Wildsmith, S. et al. (n.d.). 266 Tumour mutation burden (TMB) and efficacy outcomes in the phase III DANUBE study of advanced urothelial carcinoma (UC). Journal for immunotherapy of cancer. pp. A163-A164. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wildsmith, S. et al. (n.d.). 266 Tumour mutation burden (TMB) and efficacy outcomes in the phase III DANUBE study of advanced urothelial carcinoma (UC). Journal for immunotherapy of cancer. pp. A163-A164. [Online].